Literature DB >> 27240780

The Correlation Between 9p21 Chromosome rs4977574 Polymorphism Genotypes and the Development of Coronary Artery Heart Disease.

Oushan Tang1, Jin Lv2, Yinhong Cheng2, Fengming Qin2.   

Abstract

Our aim is to investigate the correlation between 9p21 chromosome rs4977574 polymorphism genotypes and the development of coronary artery heart disease (CHD). Two hundred and eighty-nine patients with angiography-confirmed CHD were recruited as the CHD group, while 338 subjects without CHD symptoms were enrolled as the control group. For all participating subjects, the genotypes of rs4977574 polymorphism were examined by the real-time PCR analysis. Analyses acquired from single-locus technique showed that genotype distribution of rs4977574 polymorphism was significantly different (p = 0.041) between CHD group and the control group. Logistic regression analysis demonstrated that rs4977574 polymorphism in a dominant mode significantly increased (p = 0.038) the risk of CHD, where odds ratio (OR) was 0.71 and the 95 % confidence interval (CI) 0.58-0.97 was applied. 9p21 chromosome rs4977574 polymorphism genotypes are associated with the incidence and development of CHD. The presence of C allele may reduce the risk of CHD.

Entities:  

Keywords:  Coronary artery heart disease; Gene polymorphism; Glycosylated hemoglobin

Mesh:

Year:  2017        PMID: 27240780     DOI: 10.1007/s12012-016-9372-0

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  5 in total

1.  The association between the chromosome 9p21 CDKN2B-AS1 gene variants and the lipid metabolism: A pre-diagnostic biomarker for coronary artery disease.

Authors:  Şehime Gülsün Temel; Mahmut Çerkez Ergören
Journal:  Anatol J Cardiol       Date:  2019-01       Impact factor: 1.596

2.  CDKN2B-AS1 gene rs4977574 A/G polymorphism and coronary heart disease: A meta-analysis of 40,979 subjects.

Authors:  Yan-Yan Li; Hui Wang; Yang-Yang Zhang
Journal:  J Cell Mol Med       Date:  2021-08-21       Impact factor: 5.310

3.  New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease.

Authors:  Wei Yuan; Wei Zhang; Wei Zhang; Zhong-Bao Ruan; Li Zhu; Yu Liu; Yuan-Yuan Mi; Li-Feng Zhang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

Review 4.  ANRIL polymorphism rs4977574 is associated with increased risk of coronary artery disease in Asian populations: A meta-analysis of 12,005 subjects.

Authors:  Bing Xu; Zhen Fang; Shenghu He; Junhong Wang; Xiangjun Yang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

5.  Association of ANRIL polymorphisms with coronary artery disease: A systemic meta-analysis.

Authors:  Ya-Nan Zhang; Bo Qiang; Li-Juan Fu
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.